Tesla launches $20B Terafab AI chip factory in Austin
Vertical integration push aims to reduce reliance on TSMC, Samsung for autonomous driving and robotics chips
Tesla has launched Terafab, an estimated $20 billion in-house semiconductor manufacturing facility in Austin, marking the electric vehicle maker's most ambitious foray into chip production and a dramatic expansion of its vertical integration strategy.
The facility, announced on March 21, 2026, will target cutting-edge 2-nanometer process technology with an annual production capacity of 100-200 billion AI and memory chips. The project represents one of the largest private-sector investments in semiconductor manufacturing history and underscores Tesla's determination to secure its own supply chain for the artificial intelligence chips powering its Full Self-Driving software, Cybercab robotaxis, and Optimus humanoid robots.
"Tesla's Terafab project is a vertically integrated chip fabrication effort, combining logic processing, memory production, and advanced packaging under one roof," according to MLQ.ai. "This strategy is a direct response to anticipated chip supply constraints from external foundries like TSMC and Samsung."
The initial product from Terafab will be the Tesla AI5 chip, designed to deliver 40 to 50 times more computing performance and nine times more memory than the company's current AI4 chip. These high-performance inference chips are critical to Tesla's autonomous driving ambitions and its push into robotics. The company plans to begin Cybercab production in April 2026 at Gigafactory Texas, while Optimus Version 3 production is scheduled for summer 2026, with high-volume production targeted for 2027.
The factory will feature a 10-module design, with each module capable of handling 100,000 chips monthly, potentially reaching full capacity by 2029. Mass production of the AI5 chip is anticipated by mid-2027, according to Teslarati.
Tesla shares, which had declined approximately 7% during the week through March 20, closed at $367.96 on Friday. The stock has faced pressure from regulatory challenges, including an escalated federal probe into Tesla's Full Self-Driving feature and investor concerns about execution risks associated with the massive Terafab undertaking.
Morgan Stanley analysts have maintained an Equal-Weight rating on Tesla with a $415 price target, noting the significant financial and operational risks. The investment bank described Terafab as Tesla's "most Herculean task ever" and suggested that even under an aggressive scenario, initial chip output might not occur until mid-2028 at the earliest.
The broader semiconductor industry is experiencing an AI-led recovery in 2026, with global chip sales projected to reach $975 billion, approximately half of which is expected to come from generative AI chips. Both TSMC and Samsung are making substantial investments to meet surging demand—Samsung plans to spend more than $73 billion on chips in 2026, a 22% increase from the previous year, while TSMC projects capital spending of $52 billion to $56 billion on advanced process technologies.
Tesla's vertical integration mirrors its existing strategies for battery and vehicle manufacturing, where the company has sought to control critical components of its supply chain. The AI5 chip will initially be produced by TSMC, with plans to shift production to its Arizona plant. Tesla has also secured a multi-year contract worth $16.5 billion with Samsung Electronics for the manufacturing of its next-generation AI6 chips.
However, Elon Musk has expressed that current chip partners may not be able to meet Tesla's future demand for AI chips, particularly as the company scales production of Optimus robots with a target of 10 million units annually by 2027.
Analysts caution about the complexity of building a semiconductor fabrication facility from the ground up, particularly at the leading edge of process technology. The estimated $20-25 billion cost could escalate further, and Tesla faces intense competition from established foundries that have decades of manufacturing expertise.
Despite the challenges, Terafab represents Tesla's bet that owning its chip production capacity will provide a decisive competitive advantage as autonomous driving and robotics move from development to mass deployment. With Tesla's market capitalization standing at $1.38 trillion and 44% of shares held by institutional investors, the market will be watching closely whether the company can execute on its ambitious semiconductor ambitions.